Therapies of Hematological Malignancies: An Overview of the Potential Targets and Their Inhibitors

Conclusion: The correlation of physiological proteins with cancerous hematological conditions has been discussed here. These can be crucial for the development of potent inhibitors as chemotherapeutic agents to contest such malignancies. This review will also be useful in the chemotherapeutic agent development by providing crucial information about such hematological malignancy-related proteins and their inhibitors. The repurposed drugs with potential for anticancer applications are also discussed.
Source: Current Chemical Biology - Category: Biochemistry Source Type: research